Discovery of a novel series of inhibitors of human cytomegalovirus primase

Bioorganic & Medicinal Chemistry Letters
2006.0

Abstract

Infection by human cytomegalovirus (hCMV) remains a potent threat to susceptible people throughout the world. We have discovered a series of imidazolyl-pyrimidine compounds, which were found to be irreversible inhibitors of the hCMV UL70 primase based on results from radiolabeling and SAR studies. Two promising analogs are described that rival ganciclovir and cidofovir in antiviral potency and possess improved cytotoxicity profiles.

Knowledge Graph

Similar Paper

Discovery of a novel series of inhibitors of human cytomegalovirus primase
Bioorganic & Medicinal Chemistry Letters 2006.0
SAR studies on a novel series of human cytomegalovirus primase inhibitors
Bioorganic & Medicinal Chemistry Letters 2007.0
Discovery of 1,6-Naphthyridines as a Novel Class of Potent and Selective Human Cytomegalovirus Inhibitors
Journal of Medicinal Chemistry 1999.0
Discovery of a New Family of Inhibitors of Human Cytomegalovirus (HCMV) Based upon Lipophilic Alkyl Furano Pyrimidine Dideoxy Nucleosides:  Action via a Novel Non-Nucleosidic Mechanism
Journal of Medicinal Chemistry 2004.0
Synthesis of N-Alkyl Substituted Indolocarbazoles as Potent Inhibitors of Human Cytomegalovirus Replication
Bioorganic & Medicinal Chemistry Letters 2001.0
Chlorophenylmethyl benzothiadiazine dioxides derivatives: Potent human cytomegalovirus inhibitors
Bioorganic & Medicinal Chemistry Letters 1999.0
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis of Acyclo-C-nucleosides in the Imidazo[1,2-a]pyridine and Pyrimidine Series as Antiviral Agents
Journal of Medicinal Chemistry 1996.0
3-[(3′-Hydroxymethyl)-4′-hydroxybutyl]imidazo[4,5-b]pyridines—novel antiviral agents
Bioorganic & Medicinal Chemistry Letters 1997.0
Validation and Characterization of Five Distinct Novel Inhibitors of Human Cytomegalovirus
Journal of Medicinal Chemistry 2020.0